MEETINGS - World Health Care Congress Europe 2008 (Germany) March 2008:
This article was originally published in Clinica
The World Health Care Congress Europe 2008 will take place in Berlin, Germany during March 10-12. Over 600 healthcare leaders from government and industry are expected to attend the event, and share best practices and successful initiatives for improved delivery and outcomes in Europe. For further information, contact Pascal Lardier by email: firstname.lastname@example.org www.worldcongress.com/register.cfm?confCode=HR08015
You may also be interested in...
The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.
The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US, could have potential in indications beyond epilepsy, Arvelle's CEO tells Scrip.
Biocon has reported FDA clearance for its Malaysian insulin facility, while Lupin and Xellia have also received plant approvals. Meanwhile, Alembic has seen mixed fortunes, receiving both Form 483 observations and an EIR.